BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/2/2016 1:35:00 PM | Browse: 1191 | Download: 2038
 |
Received |
|
2015-04-23 17:13 |
 |
Peer-Review Started |
|
2015-04-24 16:53 |
 |
To Make the First Decision |
|
2015-07-10 14:35 |
 |
Return for Revision |
|
2015-07-13 19:06 |
 |
Revised |
|
2015-08-31 08:42 |
 |
Second Decision |
|
2015-11-09 08:06 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-11-10 22:14 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-12-01 08:04 |
 |
Articles in Press |
|
2015-12-01 08:04 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2015-12-14 20:21 |
 |
Typeset the Manuscript |
|
2016-02-16 15:42 |
 |
Publish the Manuscript Online |
|
2016-03-02 13:35 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Basic Study |
Article Title |
Inhibition of SW620 human colon cancer cells by upregulating miRNA-145
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Chen Li, Na Xu, Yu-Qiang Li, Yu Wang and Zhi-Tu Zhu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Liaoning Medical “Principal Fund” special fund clinical construction |
XZJJ20130214 |
Liaoning Provincial Science and Technology Department of Science and Technology Program |
2013225305 |
|
Corresponding Author |
Zhi-Tu Zhu, MD, Department of Oncology, The First Affiliated Hospital of Liaoning Medical University, No. 2, Wuduan, Renmin Street, Jinzhou 121001, Liaoning Province, China. zhuzhitu2014jz@hotmail.com
|
Key Words |
miRNA-145; Colorectal cancer; Targeted therapy; N-ras; Lentiviral vector |
Core Tip |
miRNA-145 (miR-145) may play an important role in inhibiting colon cancer proliferation and invasive migration. This finding lays a good foundation for further investigation of targeting miR-145 as a tumor suppressor in colon cancer treatment, and provides novel evidence for the anti-cancer effects and therapeutic potential of miR-145.
|
Publish Date |
2016-03-02 13:35 |
Citation |
Li C, Xu N, Li YQ, Wang Y, Zhu ZT. Inhibition of SW620 human colon cancer cells by upregulating miRNA-145. World J Gastroenterol 2016; 22(9): 2771-2778 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i9/2771.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i9.2771 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345